ACP supports ACIP recommendation for second COVID-19 vaccine
PHILADELPHIA, Dec. 22 – The Ñî¹óåú´«Ã½ (ACP) supports the recommendation of the Advisory Committee on Immunization Practices (ACIP) to the Centers for Disease Control and Prevention (CDC) for the use of the COVID-19 vaccine from Moderna, Inc. to be used in persons 18 and older in the U.S. under the Food and Drug Administration’s Emergency Use Authorization. ACP previously announced its support for the ACIP recommendations to the CDC for the use of the Pfizer-BioNTech COVID-19 vaccine.